The phrase "altering risk of" is correct and usable in written English.
It can be used when discussing changes or modifications to the likelihood of a particular outcome or event occurring.
Example: "The new policy is aimed at altering the risk of data breaches in the organization."
Alternatives: "modifying the risk of" or "changing the likelihood of".
It is thought that polymorphisms within genes encoding signalling molecules may contribute to inter-individual variation in the responses to mechanical loading, potentially altering risk of injury.
We conducted a two-stage genome-wide association study to identify common genetic variation altering risk of the metabolic syndrome and related phenotypes in Indian Asian men, who have a high prevalence of these conditions.
These data in addition to the other five other genes directly or indirectly involved in altering risk of SLE by influencing DNA repair (TREX1, RAD51B, XRCC1, XRCC3, and XRCC4) implicate base excision repair, nonhomologous end joining, and homologous recombination.
However, the underlying genes from these chromosomal regions that may plausibly alter risk of migraine have not yet been identified.
Laboratory and epidemiologic studies suggest that certain dietary supplements may alter risk of cutaneous squamous cell carcinoma (SCC).
This involves practitioners seeking information on factors that alter risk of incurring specific injuries, whilst appreciating that the interactions between certain variables can modify the impact of individual risk factors.
However, few studies have examined whether established breast cancer risk factors other than histology are associated with an altered risk of breast cancer in women with benign breast disease.
Ecological consequences include the invasion and modification of sensitive ecosystems, changes in habitat provision for native taxa, altered risk of pest and pathogen outbreaks, and hybridization with native con-generics.
Together, these data provide evidence that SNPs TLR1_G1805T, TLR4_A896G, and TLR5_C1174T are associated with an altered risk of UTIs.
The existence of genetic variations that alter risk of developing both obesity and prostate cancer could constitute evidence in favour of a causal link between the two diseases.
There has been a report of other variants within the PTPN22 locus that alter risk of RA; protective haplotype '5', haplotype group '6–10' and susceptibility haplotype '4', suggesting the possibility of other PTPN22 variants involved in the pathogenesis of RA independent of R620W (R620W6601).
